跳至主要内容
临床试验/NCT06671769
NCT06671769尚未招募1 期

Natural Heart Health Supplement Trial

Efforia, Inc2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年1月15日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
60
试验地点
2
主要终点
Total Cholesterol

研究概览

简要总结

We are running a 3-month trial of an experimental natural heart health supplement. Participants will take a daily dose of an experimental natural heart health supplement in powdered format, chocolate flavor. The trial will assess changes in heart biomarkers such as Total Cholesterol, HDL-C, LDL-C, Triglycerides, and High-Sensitivity C-reactive protein (hs-CRP).

详细描述

Heart disease is a leading cause of death in the United States, and maintaining healthy cholesterol levels is crucial for heart health. While social media and the press have focused on trendier treatments for general longevity, for most of us keeping our cholesterol in check will make a major impact. Research indicates that natural substances long used in Eastern medicine, can positively affect cholesterol levels and reduce inflammation, both vital for cardiovascular wellness.

This study aims to empower participants with evidence-based insights about the effectiveness of a natural heart health supplement in managing cholesterol levels and reducing inflammation. By participating, you'll contribute to valuable research while potentially enhancing your heart health through natural means.

This study aims to assess the impact of a natural heart health supplement on Total Cholesterol, HDL-C, LDL-C, Triglycerides, and hs-CRP levels over three months. Our objective is to provide evidence supporting or refuting the supplement's efficacy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Exclusion Criteria:
  • Individuals with known soy allergies
  • Individuals with liver disease
  • Pregnant or breastfeeding individuals

排除标准

  • Individuals with known soy allergies
  • Individuals with liver disease
  • Pregnant or breastfeeding individuals

结局指标

主要结局

Total Cholesterol

时间窗: from Baseline to 30 day and 90 day.

Total Cholesterol as measured by an at-home blood collection kit returned to the lab

HDL Cholesterol

时间窗: from baseline to 30 day and 90 day

as measured by an at-home blood collection kit returned to the lab

LDL Cholesterol

时间窗: Baseline to 30 day and 90 day

as measured by an at-home blood collection kit returned to the lab

Triglycerides

时间窗: From baseline to 30 day and 90 day

as measured by at-home blood collection returned to lab

次要结局

  • hs-CRP(from baseline to 30 day and 90 day)

研究者

发起方
Efforia, Inc
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验